5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety

European Journal of Pharmacology

Volumn 463, Issue 1-3, 2003, Pages 185-197

  Groenink, Lucianne ^a   Pattij, Tommy ^a,b   De Jongh, Reinoud ^a   Van Der Gugten, Jan ^a   Oosting, Ronald S ^a   Dirks, Anneloes ^a   Olivier, Berend ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT1A receptor; Anxiety; CRF (corticotropin releasing factor); CRH (corticotropin releasing hormone); Knockout; Transgenic

Indexed keywords

BUSPIRONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DIAZEPAM; FLESINOXAN; SEROTONIN 1A RECEPTOR; UROCORTIN;

ANIMAL BEHAVIOR; ANXIETY DISORDER; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AVOIDANCE BEHAVIOR; BINDING SITE; BRAIN REGION; CONDITIONING; EXPLORATORY BEHAVIOR; FEAR; FREEZING; GENE EXPRESSION; GENE TARGETING; KNOCKOUT MOUSE; LOCOMOTION; MOUSE STRAIN; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0037470076     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01281-0     Document Type: Article

References (88)

1. Ahlers S.T., Salander M.K. Effects of repeated administration of corticotropin-releasing factor on schedule-controlled behavior in rats. Pharmacol. Biochem. Behav. 44:1993;375-380.
2. Andrews G.K., Huet-Hudson Y.M., Paria B.C., McMaster M.T., De S.K., Dey S.K. Metallothionein gene expression and metal regulation during preimplantation mouse embryo development. Dev. Biol. 145:1991;13-27.
3. Antoni F.A., Palkovits M., Makara G.B., Linton E.A., Lowry P.J., Kiss J.Z. Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract. Neuroendocrinology. 36:1983;415-423.
4. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160:1999;1-12.
5. Bagdy G., Calogero A.E., Szemeredi K., Chrousos G.P., Gold P.W. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH. Regul. Pept. 31:1990;83-92.
6. Bakshi V.P., Kalin N.H. Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions. Biol. Psychiatry. 48:2000;1175-1198.
7. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
8. Behan D.P., Grigoriadis D.E., Lovenberg T.W., Chalmers D.T., Heinrichs S.C., Liaw C.W., De Souza E.B. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol. Psychiatry. 1:1996;265-277.
9. Belzung C. The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models. Behav. Pharmacol. 12:2001;451-460.
10. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125:2001;141-149.
11. Boess F.G., Martin I.L. Review: Molecular biology of 5-HT receptors. Neuropharmacology. 33:1994;275-317.
12. Bruhn T.O., Sutton R.E., Rivier C.L., Vale W.W. Corticotropin-releasing factor regulates proopiomelanocortin messenger ribonucleic acid levels in vivo. Neuroendocrinology. 39:1984;170-175.
13. Buwalda B., de Boer S.F., van Kalkeren A.A., Koolhaas J.M. Physiological and behavioural effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology. 22:1997;297-309.
14. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
15. Coste S.C., Murray S.E., Stenzel-Poore M.P. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides. 22:2001;733-741.
16. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science. 284:1999;1670-1672.
17. Cunningham J.J., Meara P.A., Lee R.Y., Bode H.H. Chronic intracerebroventricular CRF infusion attenuates ACTH-corticosterone release. Am. J. Physiol. 255:1988;E213-E217.
18. Davidson J.R., DuPont R.L., Hedges D., Haskins J.T. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J. Clin. Psychiatry. 60:1999;528-535.
19. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety? Biol. Psychiatry. 44:1998;1239-1247.
20. Dawson G.R., Tricklebank M.D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci. 16:1995;33-36.
21. Dirks, A., 2001. Corticotropin-releasing hormone, stress, and anxiety - physiological, neuroendocrine and behavioral studies. Thesis, Utrecht University, The Netherlands, pp. 183-191.
22. 1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response. Behav. Brain Res. 118:2001;169-178.
23. Dirks A., Groenink L., Verdouw P.M., lutje Schipholt M., van der Gugten J., Hijzen T.H., Olivier B. Behavioral analysis of transgenic mice overexpressing corticotropin-releasing hormone in paradigms emulating aspects of stress, anxiety and depression. Int. J. Comp. Psychol. 14:2001;123-135.
24. Dirks A., Groenink L., Bouwknecht J.A., Hijzen T.H., van der Gugten J., Ronken E., Verbeek J.S., Veening J.G., Dederen P.J.W.C., Korosi A., Schoolderman L.F., Roubos E.W., Olivier B. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur. J. Neurosci. 16:2002;1751-1760.
25. Dirks A., Groenink L., lutje Schipholt M., van der Gugten J., Hijzen T.H., Geyer M.A., Olivier B. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biol. Psychiatry. 51:2002;583-590.
26. Dulawa S.C., Gross C., Stark K.L., Hen R., Geyer M.A. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology. 22:2000;650-659.
27. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
28. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23:1999;743-760.
29. Friedman B.H., Thayer J.F. Autonomic balance revisited: panic anxiety and heart rate variability. J. Psychosom. Research. 44:1998a;133-151.
30. Friedman B.H., Thayer J.F. Anxiety and autonomic flexibility: a cardiovascular approach. Biol. Psychiatry. 49:1998b;303-323.
31. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Ther. 65:1995;319-395.
32. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists. Psychopharmacology. 144:1999;121-130.
33. 1A receptor is not involved in emotional stress-induced rises in stress hormones. Pharmacol. Biochem. Behav. 55:1996;303-308.
34. Groenink L., Joordens R.J., Hijzen T.H., Dirks A., Olivier B. Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle. NeuroReport. 11:2000;2285-2288.
35. Groenink L., Dirks A., Verdouw P.M., lutje Schipholt M., Veening J.G., van der Gugten J., Olivier B. HPA-axis dysregulation in mice overexpressing corticotropin-releasing-hormone. Biol. Psychiatry. 51:2002;875-881.
36. 1A receptor KO mice. Biol. Psychiatry. 48:2000;1157-1163.
37. Hauger R.L., Irwin M.R., Lorang M., Aguilera G., Brown M.R. High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization. Brain Res. 616:1993;283-292.
38. Heim C., Nemeroff C.B. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol. Psychiatry. 46:1999;1509-1522.
39. Heinrichs S.C., Stenzel-Poore M.P., Gold L.H., Battenberg E.L., Bloom F.E., Koob G.F., Vale W.W., Merlo Pich E. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74:1996;303-311.
40. Heinrichs S.C., Min H., Tamraz S., Carmouche M., Boehme S.A., Vale W.W. Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology. 22:1997;215-224.
41. 1A receptor mutant mice. Proc. Natl. Acad. Sci. 95:1998;15049-15054.
42. Hodges H., Green S., Glenn B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology. 92:1987;491-504.
43. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 1996;21-30.
44. Holmes A. Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci. Biobehav. Rev. 25:2001;261-273.
45. Hotta M., Shibasaki T., Yamauchi N., Ohno H., Benoit R., Ling N., Demura H. The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones. Life Sci. 48:1991;1483-1491.
46. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
47. 1A receptor antagonists and their interaction on the fear-potentiated startle response. Psychopharmacology. 139:1998;383-390.
48. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848:1999;141-152.
49. Koob G.F., Heinrichs S.C., Merlo Pich E., Menzaghi F., Baldwin H.A., Miczek K.A., Britton K.T. The role of corticotropin-releasing factor in behavioural responses to stress. Corticotropin-Releasing Factor. CIBA Foundation Symp. vol. 172:1993;277-295 Wiley, Chichester.
50. Kozicz T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 391:1998;1-10.
51. Krahn D.D., Gosnell B.A., Majchrzak M.J. The anorectic effects of CRH and restraint stress decrease with repeated exposures. Biol. Psychiatry. 27:1990;1094-1102.
52. LeDoux J. Fear and the brain: where have we been, and where are we going? Biol. Psychiatry. 44:1998;1229-1238.
53. 1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol. Psychiatry. 28:1990;620-628.
54. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. 98:2001;7570-7575.
55. Li C., McDonald T.J. Source of corticotropin-releasing hormone-like innervation of the adrenal glands of fetal and postnatal sheep. Brain Res. 767:1997;87-91.
56. Linthorst A.C.E., Flachskamm C., Hopkins S.J., Hoadley M.E., Labeur M.S., Holsboer F., Reul J.M.H.M. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J. Neurosci. 17:1997;4448-4460.
57. Luthi A., Van der Putten H., Botteri F.M., Mansuy I.M., Meins M., Frey U., Sansig G., Portet C., Schmutz M., Schroder M., Nitsch C., Laurent J.P., Monard D. Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J. Neurosci. 17:1997;4688-4699.
58. McCall R.B., Clement M.E., Harris L.T. Studies on the mechanism of the sympatholytic effect of 8-OH DPAT: lack of correlation between inhibition of serotonin neuronal firing and sympathetic activity. Brain Res. 501:1989;73-83.
59. Meijer O.C., de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit. Rev. Neurobiol. 12:1998;1-20.
60. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry. 1:1996;336-342.
61. Olivier B., Pattij T., Wood S.J., Oosting R., Sarnyai Z., Toth M. The 5-HT(1A) receptor knockout mouse and anxiety. Behav. Pharmacol. 12:2001;439-450.
62. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. 95:1998;10734-10739.
63. Pattij T., Hijzen T.H., Groenink L., Oosting R.S., van der Gugten J., Maes R.A., Hen R., Olivier B. Stress-induced hyperthermia in the 5-HT(1A) receptor knockout mouse is normal. Biol. Psychiatry. 49:2001;569-574.
64. 1A receptor knockout mice and anxiety - behavioural and physiological studies. Thesis, Utrecht University, The Netherlands, pp. 45-58.
65. 1A receptor knockout mice. Neuropsychopharmacology. 27:2002;380-390.
66. 1A receptor knockout mice on a 129/Sv background. Eur. J. Pharmacol. 447:2002;67-74.
67. Paulus M.P., Dulawa S.C., Ralph R.J., Mark A.G. Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains. Brain Res. 835:1999;27-36.
68. Paylor R., Tracy R., Wehner J., Rudy J.W. DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behav. Neurosci. 108:1994;810-817.
69. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
70. Pineyro G., Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51:1999;533-591.
71. Radulovic J., Ruhmann A., Liepold T., Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19:1999;5016-5025.
72. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. 95:1998;14476-14481.
73. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. 98:2001;2843-2848.
74. Sarnyai Z., Sibille E.L., Pavlides C., Fenster R.J., McEwen B.S., Toth M. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc. Natl. Acad. Sci. 97:2000;14731-14736.
75. Sibille E., Pavlides C., Benke D., Toth M. Genetic inactivation of the serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J. Neurosci. 20:2000;2758-2765.
76. Steckler T., Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol. Psychiatry. 46:1999;1480-1508.
77. Stenzel-Poore M.P., Cameron V.A., Vaughan J., Sawchenko P.E., Vale W.W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130:1992;3378-3386.
78. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14:1994;2579-2584.
79. Toth M. 5-HT1A knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463:2003;177-184. (this issue).
80. Van der Staay F.J., Steckler T. Behavioural phenotyping of mouse mutants. Behav. Brain Res. 125:2001;3-12.
81. 1A receptor challenge. Genes Brain Behav. 1:2002;174-177.
82. van Gaalen M.M., Stenzel-Poore M.P., Holsboer F., Steckler T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur. J. Neurosci. 15:2002;2007-2015.
83. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428:2000;191-212.
84. 1A receptor agonist flesinoxan in panic disorder. Psychopharmacology. 127:1996;174-180.
85. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
86. Weninger S.C., Dunn A.J., Muglia L.J., Dikkes P., Miczek K.A., Swiergiel A.H., Berridge C.W., Majzoub J.A. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl. Acad. Sci. 96:1999;8283-8288.
87. Weninger S.C., Peters L.L., Majzoub J.A. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology. 141:2000;256-263.
88. Wong M.L., al Shekhlee A., Bongiorno P.B., Esposito A., Khatri P., Sternberg E.M., Gold P.W., Licinio J. Localization of urocortin messenger RNA in rat brain and pituitary. Mol. Psychiatry. 1:1996;307-312.